Syros Pharmaceuticals Inc. buy Piper Sandler
Start price
13.08.24
/
50%
€1.76
Target price
13.08.25
€4.56
Performance (%)
-16.48%
Price
14.08.24
€1.47
Summary
This prediction is currently active. The price of Syros Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.48%. This prediction currently runs until 13.08.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Syros Pharmaceuticals Inc. | -16.48% |
iShares Core DAX® | 2.722% |
iShares Nasdaq 100 | 4.546% |
iShares Nikkei 225® | 6.353% |
iShares S&P 500 | 3.194% |
Comments by Piper_Sandler for this prediction
In the thread Syros Pharmaceuticals Inc. diskutieren
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $5.00 price target on the stock, down previously from $13.00.
Ratings data for SYRS provided by MarketBeat
Stopped prediction by Piper_Sandler for Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.58
03.04.24
03.04.24
€12.01
03.04.25
03.04.25
-67.90%
14.08.24
14.08.24